On 22 October 2026, a round table “Accessibility of Medical and Pharmaceutical Services for People in Frontline Territories” was held in Kharkiv, organized by the Association of Frontline Cities and Communities together with the NGO “Association of Pharmacists of Ukraine”.
The event brought together representatives of public authorities, local communities, healthcare facilities, and the pharmaceutical community to discuss the availability of treatment in wartime, support for pharmacy infrastructure, and the development of pharmaceutical services.
One of the key topics was the organization and financing of the pharmaceutical service as an important component of ensuring the availability of medicinal products.
The pharmaceutical service involves not only dispensing medicines but also professional counseling of patients, providing information on their correct use and possible risks, and promoting safe treatment. Such assistance is of particular importance for people with chronic diseases and residents of frontline communities, where access to healthcare workers may be limited.
The round table was attended by Edem Adamanov, Director of the State Expert Center of the Ministry of Health of Ukraine. In his speech, he emphasized the need to develop an economically justified model for financing the pharmaceutical service and to integrate it into the current health care system.
In particular, several key issues were emphasized during the discussion:
- Defining the content of the pharmaceutical service. It is necessary to establish which professional actions of a pharmacist can be paid separately, what resources are needed to provide them, and by what criteria quality will be assessed.
- Economic justification of the tariff. The amount of payment should take into account the scope of the service and the necessary costs, and not automatically depend on the cost of the medicinal product.
- Alignment with existing funding mechanisms. It is important to distinguish between reimbursement of the cost of medicinal products, in particular within the “Affordable Medicines” program, and possible separate payment for professional pharmaceutical services, avoiding duplication of funding.
One possible approach to developing such a model is to test various financing options within a pilot project. This would make it possible to assess actual costs, practical conditions for providing services, and prospects for their further implementation.
Special attention was paid to the specifics of pharmacy operations in frontline communities. Security risks, complex logistics, staffing difficulties, and limited financial resources require comprehensive solutions that will take into account the real conditions of providing pharmaceutical care.
At the same time, the availability of medicinal products must be assessed taking into account the patient’s entire pathway: from a doctor’s consultation and prescription to obtaining the necessary medicine and professional assistance on its safe use.
Following the discussion, participants emphasized the importance of coordination among public authorities, local communities, healthcare facilities, and the pharmacy sector to ensure continuous access of the population to treatment.
The State Expert Center of the Ministry of Health of Ukraine is ready to participate in the further expert elaboration of the relevant decisions within its competence, in particular on issues of the safe use of medicinal products and professional information.
The development of a pharmaceutical service should be based on patient needs, modern professional standards, and economically sound funding mechanisms that will ensure its high-quality and sustainable provision.